CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
CADTH undertook a health technology assessment (HTA) to inform decision-making about the appropriate use of dialysis modalities for the treatment of end-stage kidney disease (ESKD). The HTA addressed the clinical effectiveness, cost-effectiveness, patient experiences and perspectives, ethical issues, and implementation issues of dialysis modalities for the treatment of ESKD. Optimal use recommendations were developed based on the evidence presented in the HTA.
The project has three key components:
Below is a list of articles and events related to the CADTH report on dialysis modalities :